# Evaluation of Concomitant Chemo-radiotherapy With Cisplatine vs Gemcitabin in Locally Advanced Cervicouterine Cancer

> **NCT06156514** · PHASE3 · RECRUITING · sponsor: **National Institute of Cancerología** · enrollment: 140 (estimated)

## Conditions studied

- Locally Advanced Cervical Cancer
- Gemcitabine
- Chemo-radiotherapy

## Interventions

- **DRUG:** Gemcitabine
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT06156514
- **Lead sponsor:** National Institute of Cancerología
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-11-06
- **Primary completion:** 2026-11-30
- **Final completion:** 2029-12-31
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2025-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06156514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06156514, "Evaluation of Concomitant Chemo-radiotherapy With Cisplatine vs Gemcitabin in Locally Advanced Cervicouterine Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06156514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*